{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:23:39Z","timestamp":1784651019004,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xops.2025.100963","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:07:14Z","timestamp":1760004434000},"page":"100963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["In Vitro Stability and Preclinical Safety Evaluation of High-Dose Intravitreal Topotecan in Rabbits: Impact of Dose and Concentration"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3896-4425","authenticated-orcid":false,"given":"Mar\u00eda J.","family":"Del Sole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Nejamkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Opezzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Farall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Lamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Lubieniecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Schaiquevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2025.100963_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.05.005","article-title":"Conservative management of retinoblastoma: challenging orthodoxy without compromising the state of metastatic grace. \u201cAlive, with good vision and no comorbidity.\u201d","volume":"73","author":"Munier","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2025.100963_bib2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100963_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/IAE.0b013e31821e9f8a","article-title":"Pharmacokinetic analysis of topotecan after superselective ophthalmic artery infusion and periocular administration in a porcine model","volume":"32","author":"Schaiquevich","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100963_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jjco\/hyg113","article-title":"Eye-preservation treatment of retinoblastoma with vitreous seeding","volume":"33","author":"Kaneko","year":"2003","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.xops.2025.100963_bib5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/13816810.2024.2388579","article-title":"What have we learnt about intraarterial chemotherapy (Ophthalmic Artery Chemosurgery) for retinoblastoma in the past 18 years? The third A. Linn Murphree Lecture","volume":"45","author":"Abramson","year":"2024","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.xops.2025.100963_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197081","article-title":"Ten-year experience with ophthalmic artery chemosurgery: ocular and recurrence-free survival","volume":"13","author":"Francis","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2025.100963_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/13816810.2016.1244695","article-title":"Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma","volume":"38","author":"Abramson","year":"2017","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.xops.2025.100963_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151343","article-title":"Topotecan delivery to the optic nerve after ophthalmic artery chemosurgery","volume":"11","author":"Taich","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2025.100963_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exer.2010.03.009","article-title":"Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment","volume":"91","author":"Buitrago","year":"2010","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2025.100963_bib10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1089\/jop.2015.0088","article-title":"Pharmacokinetics of Melphalan after intravitreal injection in a rabbit model","volume":"32","author":"Buitrago","year":"2016","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.xops.2025.100963_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/13816810.2014.973045","article-title":"Classification and management of seeds in retinoblastomaellsworth lecture Ghent August 24th 2013","volume":"35","author":"Munier","year":"2014","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.xops.2025.100963_bib12","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ophtha.2014.03.028","article-title":"Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study","volume":"121","author":"Francis","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100963_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.696787","article-title":"Safety and efficacy of intravitreal chemotherapy (Melphalan) to treat vitreous seeds in retinoblastoma","volume":"12","author":"Yousef","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.xops.2025.100963_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000509080","article-title":"Intravitreal Melphalan for retinoblastoma: the impact of toxicity on recurrence and ultimate globe salvage","volume":"6","author":"Berry","year":"2020","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.xops.2025.100963_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2024.12.012","article-title":"The role of intravitreal chemotherapy as an adjunctive treatment for retinoblastoma: a systematic review and single-arm meta-analysis","volume":"273","author":"Bravo-Gonzalez","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100963_bib16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/bjophthalmol-2020-316588","article-title":"Is intravitreal topotecan toxic to retinal function?","volume":"105","author":"Nadelmann","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100963_bib17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/bjophthalmol-2020-318529","article-title":"Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study","volume":"106","author":"Bogan","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100963_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.exer.2013.01.002","article-title":"Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma","volume":"108","author":"Buitrago","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2025.100963_bib19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ophtha.2024.04.022","article-title":"Intravitreal topotecan for vitreous seeds in retinoblastoma: a long-term review of 91 eyes","volume":"131","author":"Sen","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100963_bib20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.oret.2024.11.010","article-title":"Intravitreal Melphalan versus topotecan for vitreous seeds in retinoblastoma: a comparative Study of 64 Asian Indian eyes","volume":"9","author":"Agarwal","year":"2025","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.xops.2025.100963_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/bjophthalmol-2011-300498","article-title":"Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and\/or subretinal seeding: 2-Year results","volume":"96","author":"Abramson","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100963_bib22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bjophthalmol-2018-312037","article-title":"Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds","volume":"103","author":"Abramson","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100963_bib23","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.3928\/01913913-20230110-01","article-title":"Intravitreal topotecan 90 \u03bcg for recurrent solid retinoblastoma tumors is effective and not toxic","volume":"60","author":"Abramson","year":"2023","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.xops.2025.100963_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000004283","article-title":"High-Dose intravitreal topotecan for recurrent retinoblastoma, subretinal seeds, and vitreous seeds in 13 consecutive cases","volume":"45","author":"Shields","year":"2024","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100963_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/iovs.65.14.14","article-title":"Mimicking retinoblastoma treatment with repeated topotecan or Melphalan develops cross-resistance to classic agents but not to repurposed drugs","volume":"65","author":"Cancela","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100963_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/13816810.2020.1776336","article-title":"Optimizing the storage of chemotherapeutics for ophthalmic oncology: stability of topotecan solution for intravitreal injection","volume":"41","author":"Bossacoma","year":"2020","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.xops.2025.100963_bib27","first-page":"1","article-title":"Stability study of topotecan in ophthalmic prefilled syringes for intravitreal delivery","author":"Bello","year":"2025","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.xops.2025.100963_bib28","article-title":"General chapter 20.1. R\u00e8gles de Bonnes Pratiques de Fabrication de m\u00e9dicaments en petites quantit\u00e9s","volume":"12","author":"Pratiques","year":"2022","journal-title":"Pharmacopoea Helvetica"},{"key":"10.1016\/j.xops.2025.100963_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109026","article-title":"Ocular and systemic toxicity of high-dose intravitreal topotecan in rabbits: implications for retinoblastoma treatment","volume":"218","author":"Del Sole","year":"2022","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2025.100963_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146582","article-title":"Intra-arterial chemotherapy (ophthalmic artery chemosurgery) for group D retinoblastoma","volume":"11","author":"Abramson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2025.100963_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8628525","article-title":"Intravitreal melphalan chemotherapy for vitreous seeds in retinoblastoma","volume":"2020","author":"Yousef","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100963_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/IAE.0000000000002782","article-title":"Toxicity and efficacy of intravitreal melphalan for Retinoblastoma: 25 \u03bc g Versus 30 \u03bc g","volume":"41","author":"Liao","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100963_bib35","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/IAE.0000000000000903","article-title":"Intravitreous chemotherapy for active vitreous seeding from retinoblastoma","volume":"36","author":"Shields","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100963_bib36","first-page":"1","article-title":"Intraocular pressure changes following intravitreal Topotecan 90mcg\/0.18cc for the treatment of retinoblastoma","author":"Law","year":"2025","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.xops.2025.100963_bib37","first-page":"232","article-title":"Do intravitreal injections induce retinal damage?","volume":"48","author":"Ferrari","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100963_bib38","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1076\/ceyr.16.7.663.5061","article-title":"Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume","volume":"16","author":"Friedrich","year":"1997","journal-title":"Curr Eye Res"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525002611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525002611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:12:20Z","timestamp":1773814340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914525002611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666914525002611"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2025.100963","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vitro Stability and Preclinical Safety Evaluation of High-Dose Intravitreal Topotecan in Rabbits: Impact of Dose and Concentration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2025.100963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100963"}}